All lobbying filings
Thorn Run Partners
Thorn Run Partners filed a Q2 report for Boehringer Ingelheim Pharmaceuticals, Inc. on July 16, 2025, reporting $50,000 in lobbying income.
Lobbying for Boehringer Ingelheim Pharmaceuticals, Inc. · pharmaceutical company
Filing · LD-2 quarterly report
Q2 report
Reporting period
2nd Quarter 2025
Apr 1 - June 30 · Posted Jul 16, 2025
Income
$50,000
What the client paid this registrant for the period.
Client based in
Connecticut
Lobbyists on this filing
1
-
BEAU SCHUYLERPreviously held: Legislative Director: Rep. Tanner; Legislative Director: Rep. McIntyre
Government bodies contacted
2
Lobbying activity
1
Policies related to creating incentives for innovation in the life sciences.